KUVATRIS THERAPEUTICS, INC. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f0a44c5a-fe66-4b4c-a10f-5f2e32d0b3bb/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-16.1M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002911 |
| FY 2022 | $-10.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004966 |
| FY 2021 | $-7.2M | 2021-01-01 – 2021-12-31 | evidence 0001558370-23-004966 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).